Hope Biosciences Research Foundation

This phase 2 trial tested whether infusions of stem cells (HB-adMSCs) from healthy donors could help people with Parkinson's disease. 60 participants received either the stem cells or a placebo (salt water) to see if the treatment improved movement and daily living. The study is …

This phase 2 study tested whether a person's own stem cells (called HB-adMSCs) could help control Parkinson's disease symptoms. Twenty-four adults with early to moderate Parkinson's received either stem cell infusions or a placebo over 32 weeks, and were followed for safety. The …

This study tested whether a person's own stem cells (called HB-adMSCs) could improve quality of life for people with multiple sclerosis. Twenty-four adults with relapsing-remitting MS received either the stem cells or a placebo through six infusions over a year, while continuing …

This study tested whether five infusions of stem cells from donated fat tissue could help prevent COVID-19 symptoms and hospital stays in people at high risk of exposure, like healthcare workers and first responders. The trial enrolled 53 participants who had no signs of COVID-19…

This study tested whether five infusions of a person's own stem cells (HB-adMSCs) could prevent COVID-19 symptoms and hospitalization in 51 high-risk adults, such as those over 65 or with underlying health conditions. Participants had previously banked their cells at Hope Bioscie…

This study tested whether infusions of donor stem cells (HB-adMSCs) could reduce long COVID symptoms like extreme fatigue, brain fog, and headache. About 79 adults with chronic post-COVID syndrome received four IV doses of stem cells or a placebo over 10 weeks. Researchers tracke…